Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
104
Frequently Asked Questions
What is Market Cap of Korro Bio Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Korro Bio Inc. market cap is $311.59M.
What is the 52-week high for Korro Bio Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Korro Bio Inc. 52 week high is $98.00 as of September 09, 2025.
What is the 52-week low for Korro Bio Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Korro Bio Inc. 52 week low is $10.29 as of September 09, 2025.
What is Korro Bio Inc. stock price today?
Korro Bio Inc. stock price today is $32.93.
What was Korro Bio Inc. stock price yesterday?
Korro Bio Inc. stock price yesterday was $33.18.
What is the PE ratio of Korro Bio Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Korro Bio Inc.’s P/E ratio is -3.40.
What is the Price-to-Book ratio of Korro Bio Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Korro Bio Inc. P/B ratio is 2.7070.
What is the 50-day moving average of Korro Bio Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Korro Bio Inc. 50-day moving average is $16.95.
